Tech Company Financing Transactions

SpringWorks Therapeutics Funding Round

On 4/2/2019, SpringWorks Therapeutics landed $125 million in Series B investment from Perceptive Advisors, ArrowMark Partners and Bain Capital Ventures.

Transaction Overview

Company Name
SpringWorks Therapeutics
Announced On
4/2/2019
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Series B
Investors

Perceptive Advisors (Lead Investor) (Adam Stone)

ArrowMark Partners

Bain Capital Ventures

Boxer Capital

BVF Partners

GlaxoSmithKline

HBM Healthcare Investments

Laurion Capital Management

LifeArc (Peter Keen)

OrbiMed (Carl Gordon)

Pfizer Venture Investments (Freda Lewis-Hall)

Samsara BioCapital

Surveyor Capital

Proceeds Purpose
The proceeds will support the continued expansion of the Company's emerging targeted oncology programs, as well as future in-licensing opportunities and clinical collaborations in rare diseases and cancer.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Washington Blvd.
Stamford, CT 06902
USA
Phone
(203) 883-9490
Website
www.springworkstx.com
Email Address
[email protected]
Overview
SpringWorks Therapeutics (Nasdaq: SWTX) is a different type of therapeutic development company purpose-built for the 21st century. SpringWorks Therapeutics is on a mission to connect scientists, biopharmaceutical partners, patient groups, funders and philanthropists to deliver promising, transformative science to underserved patients.
Profile
SpringWorks Therapeutics LinkedIn Company Profile
Social Media
SpringWorks Therapeutics Company Twitter Account
Company News
SpringWorks Therapeutics News
Facebook
SpringWorks Therapeutics on Facebook
YouTube
SpringWorks Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Saqib Islam
  Saqib Islam LinkedIn Profile  Saqib Islam Twitter Account  Saqib Islam News  Saqib Islam on Facebook
Chief Medical Officer
Jens Renstrup
  Jens Renstrup LinkedIn Profile  Jens Renstrup Twitter Account  Jens Renstrup News  Jens Renstrup on Facebook
VP - Bus. Development
Badreddin Edris
  Badreddin Edris LinkedIn Profile  Badreddin Edris Twitter Account  Badreddin Edris News  Badreddin Edris on Facebook
VP - General Counsel
Michael Greco
  Michael Greco LinkedIn Profile  Michael Greco Twitter Account  Michael Greco News  Michael Greco on Facebook
VP - R & D
Mary Smith
  Mary Smith LinkedIn Profile  Mary Smith Twitter Account  Mary Smith News  Mary Smith on Facebook
VP - R & D
Stephen Squinto
  Stephen Squinto LinkedIn Profile  Stephen Squinto Twitter Account  Stephen Squinto News  Stephen Squinto on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/2/2019: The Block venture capital transaction
Next: 4/2/2019: Agorize venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.